Groowe Groowe / Newsroom / SNY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SNY News

Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041

globenewswire.com
SNY MRK NVS

ISPE Announces Radiopharmaceuticals Community of Practice

prnewswire.com
SNY CAH

BrightInsight Strengthens Executive Leadership Team with Three Key Hires to Accelerate Global Growth and Innovation

globenewswire.com
SNY REGN

BrightInsight Announces Multi-Million Dollar Strategic Investment to Advance its AI-Enabled Medication Persistence and Adherence Solutions

globenewswire.com
SNY REGN

Scribe Therapeutics Projected to Enter the Clinic in Mid-2026 with STX-1150, a PCSK9-targeting CRISPR Epigenetic Silencing Therapy for Durable LDL-C Reduction

businesswire.com
LLY SNY

$576.5 Million Fetal Alcohol Spectrum Disorder Treatment Market - Global Forecast 2026-2032

globenewswire.com
LLY JNJ PFE NVS SNY

Continuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica

globenewswire.com
AMGN LULU CAT REGN TMO BIIB GILD BMY MRK SNY

Allergy & Asthma Network Launches National Patient Advocacy Leadership Initiative (PALI)

prnewswire.com
AMGN AZN SNY REGN

Press Release: Myqorzo and Redemplo approved in China

globenewswire.com
SNY

House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight USA - English USA - English

prnewswire.com
ALKS STG GSK SNY TEVA AZN INCY REGN PFE BMY LLY AMGN ABBV GILD BIIB CSL VRTX BHC NVS MRK LEO ALLT CNTB INM